WHO calls halt to solidarity trial of HCQ

The World Health Organization said it has halted studies of hydroxychloroquine in its Solidarity Trial after The Lancet published a piece that said a higher mortality rate was estimated for critically ill patients who received the drug, when used alone or with a macrolide.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3emJHrQ
via IFTTT